Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 07 Aug 2020

An Externally-Validated Dynamic Nomogram Based on Clinicopathological Characteristics for Evaluating the Risk of Lymph Node Metastasis in Small-Size Non-small Cell Lung Cancer

in Thoracic Oncology

Yijun Wu
Chang Han
Zhile Wang
Liang Gong
Jianghao Liu
Yuming Chong
Xinyu Liu
Naixin Liang
Shanqing Li

Frontiers in Oncology

doi 10.3389/fonc.2020.01322

4,718 views
11 citations

Original Research

Published on 06 Aug 2020

Nestin Expression Affects Resistance to Chemotherapy and Clinical Outcome in Small Cell Lung Cancer

in Thoracic Oncology

Kazuki Sone
Ken Maeno
Ayako Masaki
Eiji Kunii
Osamu Takakuwa
Yusuke Kagawa
Akira Takeuchi
Satoshi Fukuda
Takehiro Uemura
Kensuke Fukumitsu

Frontiers in Oncology

doi 10.3389/fonc.2020.01367

4,159 views
15 citations

Original Research

Published on 06 Aug 2020

A Prognostic Nomogram Combining Immune-Related Gene Signature and Clinical Factors Predicts Survival in Patients With Lung Adenocarcinoma

in Thoracic Oncology

Congkuan Song
Zixin Guo
Donghu Yu
Yujin Wang
Qingwen Wang
Zhe Dong
Weidong Hu

Frontiers in Oncology

doi 10.3389/fonc.2020.01300

12,088 views
77 citations

Case Report

Published on 05 Aug 2020

Next-Generation Sequencing at High Sequencing Depth as a Tool to Study the Evolution of Metastasis Driven by Genetic Change Events of Lung Squamous Cell Carcinoma

in Thoracic Oncology

Hicham Mansour
Abdelhak Ouhajjou
Vladimir B. Bajic
Roberto Incitti

Frontiers in Oncology

doi 10.3389/fonc.2020.01215

6,078 views
12 citations

Original Research

Published on 05 Aug 2020

The Positive Lymph Node Ratio Predicts Survival in T1−4N1−3M0 Non-Small Cell Lung Cancer: A Nomogram Using the SEER Database

in Thoracic Oncology

Yi Liao
Guofang Yin
Xianming Fan

Frontiers in Oncology

doi 10.3389/fonc.2020.01356

6,541 views
47 citations

Case Report

Published on 31 Jul 2020

Durable Complete Response to Alectinib in a Lung Adenocarcinoma Patient With Brain Metastases and Low-Abundance EML4-ALK Variant in Liquid Biopsy: A Case Report

in Thoracic Oncology

Yingying Zhu
Ran Jia
Yang W. Shao
Liuqing Zhu
Qiuxiang Ou
Man Yu
Xue Wu
Yanbei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2020.01259

5,153 views
4 citations

Case Report

Published on 24 Jul 2020

Longitudinal Monitoring of EGFR and PIK3CA Mutations by Saliva-Based EFIRM in Advanced NSCLC Patients With Local Ablative Therapy and Osimertinib Treatment: Two Case Reports

in Thoracic Oncology

Ning Li
Udayan Guha
Chul Kim
Leah Ye
Jordan Cheng
Feng Li
David Chia
Fang Wei
David T. W. Wong

Frontiers in Oncology

doi 10.3389/fonc.2020.01240

5,145 views
11 citations

Original Research

Published on 23 Jul 2020

Comprehensive Analysis of the Immune Implication of ACK1 Gene in Non-small Cell Lung Cancer

in Thoracic Oncology

Jinhong Zhu
Yang Liu
Haijiao Ao
Mingdong Liu
Meng Zhao
Jianqun Ma

Frontiers in Oncology

doi 10.3389/fonc.2020.01132

12,682 views
27 citations

Opinion

Published on 21 Jul 2020

Palliative Care for Cancer Patients During the COVID-19 Pandemic, With Special Focus on Lung Cancer

in Thoracic Oncology

Janna J. A. O. Schoenmaekers
Lizza E. L. Hendriks
Marieke H. J. van den Beuken-van Everdingen

Frontiers in Oncology

doi 10.3389/fonc.2020.01405

7,946 views
27 citations

Case Report

Published on 17 Jul 2020

Resistance to Both Chemotherapy and EGFR-TKI in Small Cell Lung Cancer With EGFR 19-Del Mutation: A Case Report

in Thoracic Oncology

Lingfei Wang
Fangyuan Dong
Jie Su
Guanjun Du
Yang Shao
Ying Liu
Xuequn He
Liubin Bao
Wei Wang
Xin Guo

Frontiers in Oncology

doi 10.3389/fonc.2020.01048

5,118 views
3 citations

Review

Published on 16 Jul 2020

Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC)

in Thoracic Oncology

Andreas Saltos
Michael Shafique
Alberto Chiappori

Frontiers in Oncology

doi 10.3389/fonc.2020.01074

26,463 views
140 citations

Case Report

Published on 16 Jul 2020

Neoadjuvant Four-Drug Combination Therapy for NSCLC With EGFR Mutation Avoiding Total Pneumonectomy

in Thoracic Oncology

Jingpei Li
Ke Xu
Weipeng Cai
Yalei Zhang
Xin Zeng
Fei Cui
Zhexue Hao
Jun Liu
Jianxing He

Frontiers in Oncology

doi 10.3389/fonc.2020.01145

3,627 views
1 citation

Review

Published on 14 Jul 2020

Current Management and Progress in Radiotherapy for Small Cell Lung Cancer

in Thoracic Oncology

Michael C. Tjong
David Y. Mak
Jeevin Shahi
George J. Li
Hanbo Chen
Alexander V. Louie

Frontiers in Oncology

doi 10.3389/fonc.2020.01146

13,543 views
32 citations

Original Research

Published on 10 Jul 2020

LIMD1 Increases the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin via the GADD45α/p38 MAPK Signaling Pathway

in Thoracic Oncology

Xiaofei Zeng
Hong Wang
Dongsheng He
Weikun Jia
Ruidong Ma

Frontiers in Oncology

doi 10.3389/fonc.2020.00969

3,796 views
8 citations

Systematic Review

Published on 09 Jul 2020

Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer Patients With Different Metastatic Sites: A Systematic Review and Meta-Analysis

in Thoracic Oncology

Kaili Yang
Jiarui Li
Chunmei Bai
Zhao Sun
Lin Zhao

Frontiers in Oncology

doi 10.3389/fonc.2020.01098

10,310 views
43 citations

Original Research

Published on 02 Jul 2020

Mutational Portrait of Lung Adenocarcinoma in Brazilian Patients: Past, Present, and Future of Molecular Profiling in the Clinic

in Thoracic Oncology

Helano C. Freitas
Giovana Tardin Torrezan
Isabela Werneck da Cunha
Mariana Petaccia Macedo
Vanessa Karen de Sá
Marcelo Corassa
Elisa Napolitano e Ferreira
Augusto Obuti Saito
Graziela Zibetti Dal Molin
Vladmir C. Cordeiro de Lima

Frontiers in Oncology

doi 10.3389/fonc.2020.01068

5,045 views
16 citations

Original Research

Published on 30 Jun 2020

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients

in Thoracic Oncology

Yanwei Zhang
Beibei Sun
Minjuan Hu
Yuqing Lou
Jun Lu
Xueyan Zhang
Huimin Wang
Jialin Qian
Tianqing Chu
Baohui Han

Frontiers in Oncology

doi 10.3389/fonc.2020.01049

5,112 views
19 citations

Systematic Review

Published on 25 Jun 2020

Prognostic and Clinicopathological Value of Programmed Cell Death Ligand1 Expression in Patients With Small Cell Lung Cancer: A Meta-Analysis

in Thoracic Oncology

Huarong Cai
Haimei Zhang
Yuequan Jiang

Frontiers in Oncology

doi 10.3389/fonc.2020.01079

3,534 views
9 citations

Systematic Review

Published on 25 Jun 2020

Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR) Inhibitors Plus Antiangiogenic Agents as First-Line Treatments for Patients With Advanced EGFR-Mutated Non-small Cell Lung Cancer: A Meta-Analysis

in Thoracic Oncology

Fei Chen
Naifei Chen
Yu Yu
Jiuwei Cui

Frontiers in Oncology

doi 10.3389/fonc.2020.00904

10,446 views
44 citations

Original Research

Published on 24 Jun 2020

Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial

in Thoracic Oncology

Anita J. W. M. Brouns
Lizza E. L. Hendriks
Vincent van der Noort
Ben E. E. M van de Borne
Franz M. N. H. Schramel
Harry J. M. Groen
Bonne Biesma
Hans J. M. Smit
Anne-Marie C. Dingemans

Frontiers in Oncology

doi 10.3389/fonc.2020.00890

4,131 views
5 citations

Review

Published on 23 Jun 2020

Extended-Interval Dosing Strategy of Immune Checkpoint Inhibitors in Lung Cancer: Will it Outlast the COVID-19 Pandemic?

in Thoracic Oncology

Kartik Sehgal
Daniel B. Costa
Deepa Rangachari

Frontiers in Oncology

doi 10.3389/fonc.2020.01193

12,212 views
20 citations

Case Report

Published on 16 Jun 2020

A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR-KDD and Response to Afatinib

in Thoracic Oncology

Dong Chen
Xing-liang Li
Biao Wu
Xiao-bin Zheng
Wen-xian Wang
Hua-fei Chen
Yi-yu Dong
Chun-wei Xu
Mei-yu Fang

Frontiers in Oncology

doi 10.3389/fonc.2020.00867

3,878 views
13 citations

Editorial

Published on 12 Jun 2020

Editorial: Emerging Therapies for Malignant Mesothelioma

in Thoracic Oncology

Nico van Zandwijk
Glen Reid
Paul Baas

Frontiers in Oncology

doi 10.3389/fonc.2020.00939

3,608 views
3 citations

Original Research

Published on 11 Jun 2020

Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis

in Thoracic Oncology

Weidong Wang
Dongni Chen
Weiwei Chen
Ziya Xin
Zirui Huang
Xuewen Zhang
Kexing Xi
Gongming Wang
Rusi Zhang
Dechang Zhao

Frontiers in Oncology

doi 10.3389/fonc.2020.00855

6,796 views
21 citations

1,971 articles

articles

An Externally-Validated Dynamic Nomogram Based on Clinicopathological Characteristics for Evaluating the Risk of Lymph Node Metastasis in Small-Size Non-small Cell Lung Cancer

Nestin Expression Affects Resistance to Chemotherapy and Clinical Outcome in Small Cell Lung Cancer

A Prognostic Nomogram Combining Immune-Related Gene Signature and Clinical Factors Predicts Survival in Patients With Lung Adenocarcinoma

Next-Generation Sequencing at High Sequencing Depth as a Tool to Study the Evolution of Metastasis Driven by Genetic Change Events of Lung Squamous Cell Carcinoma

The Positive Lymph Node Ratio Predicts Survival in T1−4N1−3M0 Non-Small Cell Lung Cancer: A Nomogram Using the SEER Database

Durable Complete Response to Alectinib in a Lung Adenocarcinoma Patient With Brain Metastases and Low-Abundance EML4-ALK Variant in Liquid Biopsy: A Case Report

Longitudinal Monitoring of EGFR and PIK3CA Mutations by Saliva-Based EFIRM in Advanced NSCLC Patients With Local Ablative Therapy and Osimertinib Treatment: Two Case Reports

Comprehensive Analysis of the Immune Implication of ACK1 Gene in Non-small Cell Lung Cancer

Palliative Care for Cancer Patients During the COVID-19 Pandemic, With Special Focus on Lung Cancer

Resistance to Both Chemotherapy and EGFR-TKI in Small Cell Lung Cancer With EGFR 19-Del Mutation: A Case Report

Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC)

Neoadjuvant Four-Drug Combination Therapy for NSCLC With EGFR Mutation Avoiding Total Pneumonectomy

Current Management and Progress in Radiotherapy for Small Cell Lung Cancer

LIMD1 Increases the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin via the GADD45α/p38 MAPK Signaling Pathway

Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer Patients With Different Metastatic Sites: A Systematic Review and Meta-Analysis

Mutational Portrait of Lung Adenocarcinoma in Brazilian Patients: Past, Present, and Future of Molecular Profiling in the Clinic

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients

Prognostic and Clinicopathological Value of Programmed Cell Death Ligand1 Expression in Patients With Small Cell Lung Cancer: A Meta-Analysis

Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR) Inhibitors Plus Antiangiogenic Agents as First-Line Treatments for Patients With Advanced EGFR-Mutated Non-small Cell Lung Cancer: A Meta-Analysis

Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial

Extended-Interval Dosing Strategy of Immune Checkpoint Inhibitors in Lung Cancer: Will it Outlast the COVID-19 Pandemic?

A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR-KDD and Response to Afatinib

Editorial: Emerging Therapies for Malignant Mesothelioma

Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis